![](/img/cover-not-exists.png)
P-112 Response to azacitidine is independent of TP53 mutations in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia
Mueller-Thomas, C., Rudelius, M., Wolf, P., Schanz, J., Schmidt, B., Platzbecker, U., Germing, U., Peschel, C., Goetze, K.Volume:
37
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/S0145-2126(13)70160-7
Date:
May, 2013
File:
PDF, 206 KB
english, 2013